Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Richard Hellmund"'
Publikováno v:
Diabetes Therapy. 13:1933-1945
For people with type 2 diabetes (T2D) on intensive insulin therapy, the use of flash continuous glucose monitoring ("flash monitoring") is associated with improved average glucose control and/or reduced hypoglycemic exposure. This study assessed the
Autor:
Richard, Hellmund, Zoë, Welsh
Publikováno v:
Diabetic Medicine. 40
Publikováno v:
Diabetes. 70
Despite evidence pointing to clinical benefits of CGM, access has been limited by many state Medicaid plans. We assessed the budget impact of providing flash CGM to members with type 1 (T1D) or type 2 diabetes (T2D) taking multiple daily injections o
Publikováno v:
European Endocrinology
Flash glucose monitoring – an alternative to traditional self-monitoring of blood glucose (SMBG) – prevents hypoglycaemic events without impacting glycated haemoglobin (HbA1c).21Given the potential benefits, this study assessed the cost-effective
Publikováno v:
Diabetes Technology & Therapeutics. 23:S-36
Objective: We assessed the economic impact of using the newest flash continuous glucose monitoring (CGM) among Medicaid beneficiaries with diabetes treated with intensive insulin therapy (IIT). Res...
Publikováno v:
Diabetes. 68
Background: Type 1 diabetes (T1D) patients with impaired awareness of hypoglycemia (IAH) face higher risk of severe hypoglycemic events. Continuous glucose monitoring (CGM) has been found to prevent severe hypoglycemic events in this population (van
Autor:
Richard Hellmund, Lizheng Shi
Publikováno v:
US Endocrinology. 16:24
Autor:
Richard Hellmund
Publikováno v:
Diabetes. 67
Background: A novel, factory-calibrated, flash continuous glucose monitoring system (flash CGM; FreeStyle Libre™ system) was approved by FDA in September 2017. The clinical benefit of flash CGM as a replacement for routine self-monitoring of blood
Publikováno v:
European Endocrinology
Aims:Estimate the costs associated with flash glucose monitoring as a replacement for routine self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes mellitus (T2DM) using intensive insulin, from a UK National Health Service (NHS) pe
Publikováno v:
Diabetes research and clinical practice. 138
Aims To estimate the costs associated with a flash glucose monitoring system as a replacement for routine self-monitoring of blood glucose (SMBG) in patients with type 1 diabetes mellitus (T1DM) using intensive insulin, from a UK National Health Serv